Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.
2.

Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.

Daniel R, Smith JA.

Hum Gene Ther. 2008 Jun;19(6):557-68. doi: 10.1089/hum.2007.148. Review.

3.

Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.

Modlich U, Bohne J, Schmidt M, von Kalle C, Knöss S, Schambach A, Baum C.

Blood. 2006 Oct 15;108(8):2545-53.

4.

Retroviral vectors: post entry events and genomic alterations.

Nowrouzi A, Glimm H, von Kalle C, Schmidt M.

Viruses. 2011 May;3(5):429-55. doi: 10.3390/v3050429. Review.

5.

Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.

Sokol M, Wabl M, Ruiz IR, Pedersen FS.

Retrovirology. 2014 May 19;11:36. doi: 10.1186/1742-4690-11-36.

6.

Gene specificity of suppression of transgene-mediated insertional transcriptional activation by the chicken HS4 insulator.

Desprat R, Bouhassira EE.

PLoS One. 2009 Jun 18;4(6):e5956. doi: 10.1371/journal.pone.0005956.

7.

Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.

Bosticardo M, Ghosh A, Du Y, Jenkins NA, Copeland NG, Candotti F.

Mol Ther. 2009 Nov;17(11):1910-8. doi: 10.1038/mt.2009.172.

8.

Structure-based prediction of insertion-site preferences of transposons into chromosomes.

Geurts AM, Hackett CS, Bell JB, Bergemann TL, Collier LS, Carlson CM, Largaespada DA, Hackett PB.

Nucleic Acids Res. 2006 May 22;34(9):2803-11.

9.
10.
11.

Yeast vectors for the integration/expression of any sequence at the TYR1 locus.

Mirisola MG, Colomba L, Gallo A, Amodeo R, De Leo G.

Yeast. 2007 Sep;24(9):761-6.

12.

Retrovirus-induced oncogenesis and safety of retroviral vectors.

Nair V.

Curr Opin Mol Ther. 2008 Oct;10(5):431-8. Review.

PMID:
18830918
13.

Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.

Moldt B, Staunstrup NH, Jakobsen M, Yáñez-Muñoz RJ, Mikkelsen JG.

BMC Biotechnol. 2008 Aug 9;8:60. doi: 10.1186/1472-6750-8-60.

14.

High-throughput genomic mapping of vector integration sites in gene therapy studies.

Beard BC, Adair JE, Trobridge GD, Kiem HP.

Methods Mol Biol. 2014;1185:321-44. doi: 10.1007/978-1-4939-1133-2_22.

PMID:
25062639
15.

Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors.

Moldt B, Yant SR, Andersen PR, Kay MA, Mikkelsen JG.

Hum Gene Ther. 2007 Dec;18(12):1193-204.

PMID:
17988194
16.

piggyBac as a high-capacity transgenesis and gene-therapy vector in human cells and mice.

Li R, Zhuang Y, Han M, Xu T, Wu X.

Dis Model Mech. 2013 May;6(3):828-33. doi: 10.1242/dmm.010827.

17.

Targeted gene insertion for molecular medicine.

Voigt K, Izsvák Z, Ivics Z.

J Mol Med (Berl). 2008 Nov;86(11):1205-19. doi: 10.1007/s00109-008-0381-8. Review.

PMID:
18607557
18.

Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.

Baum C, Kustikova O, Modlich U, Li Z, Fehse B.

Hum Gene Ther. 2006 Mar;17(3):253-63. Review.

PMID:
16544975
19.

RTCGD: retroviral tagged cancer gene database.

Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG.

Nucleic Acids Res. 2004 Jan 1;32(Database issue):D523-7.

20.

Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage.

Grandchamp N, Altémir D, Philippe S, Ursulet S, Pilet H, Serre MC, Lenain A, Serguera C, Mallet J, Sarkis C.

PLoS One. 2014 Jun 23;9(6):e99649. doi: 10.1371/journal.pone.0099649.

Items per page

Supplemental Content

Support Center